Skip to main content
Erschienen in: Wiener klinische Wochenschrift 8/2016

01.12.2016 | original article

Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models

verfasst von: Hikmetullah Batgi, MD, Erdem Akbal, MD, Erdem Koçak, MD, Assoc Prof Ömer Akyürek, MD, Assoc Prof Seyfettin Köklü, MD, Melahat Dönmez, MD, Fahri Güneş

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 8/2016

Einloggen, um Zugang zu erhalten

Summary

Background

Ankaferd blood stopper (ABS) is a herbal extract that enhances mucosal healing. It has therapeutic potential in the management of external hemorrhage and controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures. The aim of this experimental study was to assess the effects of ABS on hemorrhagic lesions and compare them with omeprazole.

Methods

The study was conducted on 30 rats. Rats were divided into five groups: group A (only indomethacin), group B (ABS administration 60 min before indomethacin-induced injury), group C (ABS administration 30 min after indomethacin-induced injury), group D (omeprazole administration 60 min before indomethacin‐induced injury), group E (omeprazole administration 30 min after indomethacin‐induced injury). Gastric mucosal lesions were produced by indomethacin in all three groups. The effect was studied morphologically 6 h after oral administration of the drug. Subsequently, affected tissue was examined histologically.

Results

Based on the number and the total size of hemorrhagic lesions, the hemorrhagic lesion scores were significantly better in Group C compared to other groups (p < 0.05). The hemorrhagic lesion score of Group B was significantly better than Group D and Group A (p < 0.05). Omeprazole groups (Group D, Group E) did not show significant improvement as indicated by macroscopic scores. There was no significant difference between the groups with respect to microscopic scores.

Conclusion

These results indicate that ABS has a potent inhibitory action on indomethacin-induced gastric bleeding and mucosal lesions and it is useful in the treatment of acute gastric mucosal lesions.
Literatur
1.
Zurück zum Zitat Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev. 2010 Dec;15(4):329–36. Review.PubMed Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev. 2010 Dec;15(4):329–36. Review.PubMed
2.
Zurück zum Zitat Göker H, Haznedaroglu IC, Erçetin S, Kirazlı S, Akman U, Öztürk Y, Fırat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:163–70.CrossRefPubMed Göker H, Haznedaroglu IC, Erçetin S, Kirazlı S, Akman U, Öztürk Y, Fırat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:163–70.CrossRefPubMed
3.
Zurück zum Zitat Haznedaroglu BZ, Haznedaroglu IC, Walker SL, et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost. 2010;16:446–53.CrossRefPubMed Haznedaroglu BZ, Haznedaroglu IC, Walker SL, et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost. 2010;16:446–53.CrossRefPubMed
4.
Zurück zum Zitat Al B, Yildirim C, Cavdar M, et al. Effectiveness of Ankaferd Blood Stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J. 2009;30:1520–5.PubMed Al B, Yildirim C, Cavdar M, et al. Effectiveness of Ankaferd Blood Stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J. 2009;30:1520–5.PubMed
5.
Zurück zum Zitat Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73:1742–5.CrossRefPubMed Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73:1742–5.CrossRefPubMed
6.
Zurück zum Zitat Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010;267:1377–81.CrossRefPubMed Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010;267:1377–81.CrossRefPubMed
7.
Zurück zum Zitat Kurt M, Kacar S, Onal IK, et al. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40:E262.CrossRefPubMed Kurt M, Kacar S, Onal IK, et al. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40:E262.CrossRefPubMed
8.
Zurück zum Zitat Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42:196–9.CrossRefPubMed Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42:196–9.CrossRefPubMed
9.
Zurück zum Zitat Koçak E, Akbal E, Taş A, Köklü S, Karaca G, Can M, Kösem B, Üstün H. Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi J Gastroenterol. 2013 May–Jun;19(3):126–30.CrossRefPubMedPubMedCentral Koçak E, Akbal E, Taş A, Köklü S, Karaca G, Can M, Kösem B, Üstün H. Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi J Gastroenterol. 2013 May–Jun;19(3):126–30.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Beyazit Y, Köklü S, Akbal E, Kurt M, Kekilli M, Haznedaroglu IC. Successful treatment of endoscopic sphincterotomy-induced early hemorrhage with application of Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Dec;72(6):1325–6.CrossRefPubMed Beyazit Y, Köklü S, Akbal E, Kurt M, Kekilli M, Haznedaroglu IC. Successful treatment of endoscopic sphincterotomy-induced early hemorrhage with application of Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Dec;72(6):1325–6.CrossRefPubMed
11.
Zurück zum Zitat Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd Blood Stopper. Hepatogastroenterology. 2010;57:191–4.PubMed Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd Blood Stopper. Hepatogastroenterology. 2010;57:191–4.PubMed
12.
Zurück zum Zitat Arslan S, Oz B, Haznedaroglu IC, Goker H. Endobronchial application of Ankaferd Blood Stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respir Med CME. 2009;2:144–6.CrossRef Arslan S, Oz B, Haznedaroglu IC, Goker H. Endobronchial application of Ankaferd Blood Stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respir Med CME. 2009;2:144–6.CrossRef
13.
Zurück zum Zitat Dogan OF, Ozyurda U, Uymaz OK, et al. New anticoagulant agent for CABG surgery. Eur J Clin Invest. 2008;38:341.CrossRef Dogan OF, Ozyurda U, Uymaz OK, et al. New anticoagulant agent for CABG surgery. Eur J Clin Invest. 2008;38:341.CrossRef
14.
Zurück zum Zitat Akbal E, Köklü S, Astarcı HM, Koçak E, Karaca G, Beyazıt Y, Topcu G, Acar B, Ergün D, Haznedaroğlu İC. Oral high-dose ankaferd administration effects on gastrointestinal system. Int J Med Sci. 2013;10(4):451–6CrossRefPubMedPubMedCentral Akbal E, Köklü S, Astarcı HM, Koçak E, Karaca G, Beyazıt Y, Topcu G, Acar B, Ergün D, Haznedaroğlu İC. Oral high-dose ankaferd administration effects on gastrointestinal system. Int J Med Sci. 2013;10(4):451–6CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Akbal E, Köklü S, Karaca G, Astarcı HM, Koçak E, Taş A, Beyazıt Y, Haznedaroğlu İ. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Dis Esophagus. 2012 Apr;25(3):188–94. doi: 10.1111/j.1442-2050.2011.01231.x. Epub 2011 Aug 5. Akbal E, Köklü S, Karaca G, Astarcı HM, Koçak E, Taş A, Beyazıt Y, Haznedaroğlu İ. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Dis Esophagus. 2012 Apr;25(3):188–94. doi: 10.1111/j.1442-2050.2011.01231.x. Epub 2011 Aug 5.
16.
Zurück zum Zitat Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd Blood Stopper. J Altern Complement Med. 2008;14:1073–4.CrossRefPubMed Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd Blood Stopper. J Altern Complement Med. 2008;14:1073–4.CrossRefPubMed
17.
Zurück zum Zitat Ozaslan E, Purnak T, Haznedaroglu IC. Ankaferd Blood Stopper in GI bleeding: alternative for everything? Gastrointest Endosc. 2011 Jan;73(1):185–6; author reply 186–7. Ozaslan E, Purnak T, Haznedaroglu IC. Ankaferd Blood Stopper in GI bleeding: alternative for everything? Gastrointest Endosc. 2011 Jan;73(1):185–6; author reply 186–7.
18.
Zurück zum Zitat Okten S, Kurt M, Onal IK, Haznedaroglu IC. Use of Ankaferd Blood Stopper for controlling actively bleeding fundal varices. Singapore Med J. 2011 Jan; 52(1):e11–2.PubMed Okten S, Kurt M, Onal IK, Haznedaroglu IC. Use of Ankaferd Blood Stopper for controlling actively bleeding fundal varices. Singapore Med J. 2011 Jan; 52(1):e11–2.PubMed
19.
Zurück zum Zitat Ozaslan E, Purnak T, Ozyigit G, Akyol F, Yildiz A, Haznedaroglu IC. No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis. Endoscopy. 2010;42Suppl 2:E271–2. Epub 2010 Oct 7. Ozaslan E, Purnak T, Ozyigit G, Akyol F, Yildiz A, Haznedaroglu IC. No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis. Endoscopy. 2010;42Suppl 2:E271–2. Epub 2010 Oct 7.
20.
Zurück zum Zitat Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M. Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma. J Invest Surg. 2010 Jun;23(3):175.CrossRefPubMed Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M. Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma. J Invest Surg. 2010 Jun;23(3):175.CrossRefPubMed
21.
Zurück zum Zitat Purnak T, Ozaslan E, Beyazit Y, Haznedaroglu IC. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. Phytother Res. 2011 Feb;25(2):312–3. doi: 10.1002/ptr.3252.PubMed Purnak T, Ozaslan E, Beyazit Y, Haznedaroglu IC. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. Phytother Res. 2011 Feb;25(2):312–3. doi: 10.1002/ptr.3252.PubMed
22.
Zurück zum Zitat Murakami M, Saita H, Teramura S, Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology 1993;105:1710–5.CrossRefPubMed Murakami M, Saita H, Teramura S, Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology 1993;105:1710–5.CrossRefPubMed
23.
Zurück zum Zitat Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
24.
Zurück zum Zitat Toapanta-Yanchapaxi L, Chavez-Tapia N, Téllez-Ávila F. Cyanoacrylate spray as treatment in difficult-to-manage gastrointestinal bleeding. World J Gastrointest Endosc. 2014 Sep 16;6(9):448–52. Toapanta-Yanchapaxi L, Chavez-Tapia N, Téllez-Ávila F. Cyanoacrylate spray as treatment in difficult-to-manage gastrointestinal bleeding. World J Gastrointest Endosc. 2014 Sep 16;6(9):448–52.
25.
Zurück zum Zitat Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol. 2010 Jul;29(4):166–8. Epub 2010 Sep 3.CrossRefPubMed Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol. 2010 Jul;29(4):166–8. Epub 2010 Sep 3.CrossRefPubMed
26.
Zurück zum Zitat Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Apr;71(4):873–5. Epub 2009 Nov 17CrossRefPubMed Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Apr;71(4):873–5. Epub 2009 Nov 17CrossRefPubMed
27.
Zurück zum Zitat Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis. 2011 Mar;43(3):247–8. Epub 2010 Dec 21CrossRefPubMed Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis. 2011 Mar;43(3):247–8. Epub 2010 Dec 21CrossRefPubMed
28.
Zurück zum Zitat Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis. 2010 Aug;42(8):594–5. Epub 2009 Dec 11.CrossRefPubMed Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis. 2010 Aug;42(8):594–5. Epub 2009 Dec 11.CrossRefPubMed
29.
Zurück zum Zitat Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper: a novel indication (with video). Gastrointest Endosc. 2010;72:666–7.CrossRefPubMed Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper: a novel indication (with video). Gastrointest Endosc. 2010;72:666–7.CrossRefPubMed
30.
Zurück zum Zitat Taş A, Köklü S, Beyazit Y, Karaca G, Astarcı HM, Akbal E, Koçak E, Topçu G, Haznedaroglu IC. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Clin Res Hepatol Gastroenterol. 2011 Sep;35(8–9):549–53. Taş A, Köklü S, Beyazit Y, Karaca G, Astarcı HM, Akbal E, Koçak E, Topçu G, Haznedaroglu IC. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Clin Res Hepatol Gastroenterol. 2011 Sep;35(8–9):549–53.
31.
Zurück zum Zitat Kosar A, Cipil HS, Kaya A, et al. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis. 2009;20:185–90.CrossRefPubMed Kosar A, Cipil HS, Kaya A, et al. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis. 2009;20:185–90.CrossRefPubMed
32.
Zurück zum Zitat Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.CrossRefPubMed Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.CrossRefPubMed
33.
Zurück zum Zitat Kılıçgün A, Sarıkaş NG, Korkmaz T, Saydam O, Boran C, Boztaş G. Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study. J Cardiothorac Surg. 2011 Feb 27;6:20.CrossRefPubMedPubMedCentral Kılıçgün A, Sarıkaş NG, Korkmaz T, Saydam O, Boran C, Boztaş G. Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study. J Cardiothorac Surg. 2011 Feb 27;6:20.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat İşler SC, Demircan S, Cakarer S, et al. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci. 2010;18:409–14.PubMed İşler SC, Demircan S, Cakarer S, et al. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci. 2010;18:409–14.PubMed
35.
Zurück zum Zitat Cipil HS, Kosar A, Kaya A, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009;15:270–6.CrossRefPubMed Cipil HS, Kosar A, Kaya A, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009;15:270–6.CrossRefPubMed
36.
Zurück zum Zitat Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J. 2010 Aug;30(8):864–8. Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J. 2010 Aug;30(8):864–8.
37.
Zurück zum Zitat Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.CrossRefPubMed Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.CrossRefPubMed
38.
Zurück zum Zitat Beyazit Y, Onder FO, Torun S, Tas A, Purnak T, Tenlik I, Turhan N. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. Blood Coagul Fibrinolysis. 2013 Oct;24(7):762–5. Beyazit Y, Onder FO, Torun S, Tas A, Purnak T, Tenlik I, Turhan N. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. Blood Coagul Fibrinolysis. 2013 Oct;24(7):762–5.
39.
Zurück zum Zitat Ercetin S, Haznedaroglu IC, Kurt M, et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery. UHOD. 2010;20:1–5.CrossRef Ercetin S, Haznedaroglu IC, Kurt M, et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery. UHOD. 2010;20:1–5.CrossRef
Metadaten
Titel
Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models
verfasst von
Hikmetullah Batgi, MD
Erdem Akbal, MD
Erdem Koçak, MD
Assoc Prof Ömer Akyürek, MD
Assoc Prof Seyfettin Köklü, MD
Melahat Dönmez, MD
Fahri Güneş
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 8/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0762-2

Weitere Artikel der Sonderheft 8/2016

Wiener klinische Wochenschrift 8/2016 Zur Ausgabe